Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.36 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6162575 | 0.90 | CXCR1 (0.40) | MEN1KMT2ATSHRMAPK14ALDH1A1 | |
| SCHEMBL6161347 | 0.73 | CA12 (0.56) | KMT2ATSHRALDH1A1LMNAHSD17B10 | |
| SCHEMBL12471098 | 0.70 | RAB9A (0.57) | MEN1KMT2ATSHRMAPK14ALDH1A1 | |
| SCHEMBL13471446 | 0.70 | MAPT (0.42) | MEN1KMT2ATSHRALDH1A1RAB9A | |
| SCHEMBL2585487 | 0.67 | TSHR (0.67) | MEN1KMT2ATSHRALDH1A1LMNA | |
| SCHEMBL14353413 | 0.67 | TSHR (0.67) | MEN1KMT2ATSHRALDH1A1LMNA | |
| SCHEMBL11218066 | 0.66 | ALDH1A1 (0.66) | MEN1KMT2AALDH1A1RAB9ALMNA | |
| SCHEMBL20545474 | 0.66 | RAB9A (0.52) | MEN1KMT2ATSHRMAPK14ALDH1A1 | |
| SCHEMBL628936 | 0.66 | — | — | |
| SCHEMBL18154877 | 0.65 | KMT2A (0.47) | MEN1KMT2ATSHRALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934310-B1 | THIO ACID DERIVED MONOCYCLIC N-HETEROCYCLICS AS ANTICOAGULANTS | SCHERING AG (DE) | 2005-02-09 | — | — | EP | disclosed |
| US-6221886-B1 | Thio acid derived monocyclic N-heterocyclics as anticoagulants | BERLEX LABORATORIES, INC. | 2001-04-24 | — | — | US | disclosed |
| US-6166014-A | Thio acid derived monocyclic N-heterocyclics as anticoagulants | BERLEX LABORATORIES, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| US-6162807-A | Thio acid derived monocyclic N-heterocyclics as anticoagulants | BERLEX LABORATORIES, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| US-6150382-A | ENZYME INHIBITORS OF BLOOD COAGULATION FACTOR XA, A SERINE PROTEASE CLASS OF ENZYMES; E.G., 4-HYDROXY-3-((4-(2-CARBOXY-METHYL)THIO-6-(3-(1-METHYL)-6-(3-(1 -METHYL)IMIDAZOLIN-2-YL)-PHENOXY-3,5-DIFLUOROPYRIDINE AND DERIVATIVES | BERLEX LABORATORIES, INC. (US) | 2000-11-21 | — | — | US | disclosed |
| US-6034084-A | CARDIOVASCULAR DISORDERS | BERLEX LABORATORIES, INC. (US) | 2000-03-07 | — | — | US | disclosed |
| US-6004985-A | BLOOD-COAGULATION FACTOR XA INHIBITORS | BERLEX LABORATORIES, INC. (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0934310-A1 | THIO ACID DERIVED MONOCYCLIC $i(N)-HETEROCYCLICS AS ANTICOAGULANTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998015547-A1 | THIO ACID DERIVED MONOCYCLIC N-HETEROCYCLICS AS ANTICOAGULANTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-04-16 | — | — | WO | disclosed |